Publications by authors named "Josep Fortea"

Claim this Profile
U
Utility of nintedanib for severe idiopathic pulmonary fibrosis: a single-center retrospective study [Letter].
Leticia Orsatti, Josep Fortea, Manuel Quaresma

Drug Des Devel Ther· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An exploration of the barriers to the confident diagnosis of irritable bowel syndrome: A survey among general practitioners, gastroenterologists and experts in five European countries.
Viola Andresen, Peter Whorwell, Josep Fortea, Sébastien Auzière

United European Gastroenterol J· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Burden of constipation-predominant irritable bowel syndrome (IBS-C) in France, Italy, and the United Kingdom.
Marco Dacosta Dibonaventura, Mercedes Prior, Pablo Prieto, Josep Fortea

Clin Exp Gastroenterol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient assessment of onset of action and overall satisfaction with ebastine fast-dissolving tablets in allergic rhinitis.
Albert Roger, Josep Fortea, Sheila Mora, Maite Artés

Expert Rev Pharmacoecon Outcomes Res· August 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of ebastine 10 mg fast-dissolving tablet with oral desloratadine and placebo in inhibiting the cutaneous reaction to histamine in healthy adults.
Rosa M Antonijoan, Consuelo García-Gea, Montserrat Puntes, Marta Valle, Ramon Esbri, Josep Fortea

Clin Drug Investig· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Incidence of spontaneous notifications of adverse reactions with aceclofenac, meloxicam, and rofecoxib during the first year after marketing in the United Kingdom.
Anna Raber, Joan Heras, Joan Costa, Josep Fortea, Albert Cobos

Ther Clin Risk Manag· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of inhibition of cutaneous histamine reaction of ebastine fast-dissolving tablet (20 mg) versus desloratadine capsule (5 mg): a randomized, double-blind, double-dummy, placebo-controlled, three-period crossover study in healthy, nonatopic adults.
Rosa Antonijoan, Consuelo García-Gea, Montserrat Puntes, Joselin Pérez, Ramón Esbrí, Josep Fortea

Clin Ther· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and safety of aceclofenac versus placebo and naproxen in women with primary dysmenorrhoea.
Heinz Letzel, Yves Mégard, Rosa Lamarca, Anna Raber, Josep Fortea

Eur J Obstet Gynecol Reprod Biol· December 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis